GSK (LON:GSK) Sets New 52-Week High at $1,767.50

GSK plc (LON:GSK - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 1,767.50 ($22.20) and last traded at GBX 1,762.54 ($22.14), with a volume of 15331153 shares. The stock had previously closed at GBX 1,733.50 ($21.78).

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an "underweight" rating in a report on Thursday, May 2nd. Shore Capital reaffirmed a "buy" rating on shares of GSK in a report on Wednesday, May 1st. Berenberg Bank lifted their price target on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the stock a "buy" rating in a report on Wednesday, February 14th. Barclays restated an "equal weight" rating and issued a GBX 1,725 ($21.67) price objective on shares of GSK in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 1,950 ($24.50) target price on shares of GSK in a research report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of GBX 1,675.63 ($21.05).

GSK Price Performance

The business has a 50 day simple moving average of GBX 1,666.29 and a two-hundred day simple moving average of GBX 1,562.88. The firm has a market capitalization of £72.54 billion, a P/E ratio of 1,477.92, a price-to-earnings-growth ratio of 1.12 and a beta of 0.27. The company has a debt-to-equity ratio of 140.82, a quick ratio of 0.73 and a current ratio of 0.88.

GSK Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be issued a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK's dividend payout ratio is currently 5,333.33%.

Insider Buying and Selling at GSK

In other news, insider Urs Rohner acquired 434 shares of the firm's stock in a transaction that occurred on Wednesday, March 20th. The shares were bought at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). In related news, insider Urs Rohner bought 434 shares of the stock in a transaction dated Wednesday, March 20th. The stock was bought at an average price of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). Also, insider Emma Walmsley sold 139,792 shares of GSK stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,747.94). Company insiders own 1.77% of the company's stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.